[go: up one dir, main page]

CN109485658B - Preparation method of ceftezole acid - Google Patents

Preparation method of ceftezole acid Download PDF

Info

Publication number
CN109485658B
CN109485658B CN201811387629.0A CN201811387629A CN109485658B CN 109485658 B CN109485658 B CN 109485658B CN 201811387629 A CN201811387629 A CN 201811387629A CN 109485658 B CN109485658 B CN 109485658B
Authority
CN
China
Prior art keywords
acid
reaction
ceftezole
preparation
thiadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811387629.0A
Other languages
Chinese (zh)
Other versions
CN109485658A (en
Inventor
刘明霞
李俊广
王琳琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co ltd
Shandong Yuxin Pharmaceutical Co ltd
Shandong Luoxin Pharmaceutical Group Co Ltd
Original Assignee
Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co ltd
Shandong Yuxin Pharmaceutical Co ltd
Shandong Luoxin Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co ltd, Shandong Yuxin Pharmaceutical Co ltd, Shandong Luoxin Pharmaceutical Group Co Ltd filed Critical Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co ltd
Priority to CN201811387629.0A priority Critical patent/CN109485658B/en
Publication of CN109485658A publication Critical patent/CN109485658A/en
Application granted granted Critical
Publication of CN109485658B publication Critical patent/CN109485658B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The invention discloses a preparation method of ceftezole acid, belonging to the technical field of medicine synthesis. The invention adopts 2-mercapto-1, 3, 4-thiadiazole and 7-ACA to react to prepare an intermediate 1, the prepared intermediate 1 reacts with tetrazoleacetic acid, and a series of post-treatments are carried out to prepare the ceftezole acid. The preparation method shortens the reaction route, is easy to operate, has higher yield and purity, has few by-products, has the advantage of environmental protection, and is suitable for industrial production.

Description

Preparation method of ceftezole acid
Technical Field
The invention belongs to the technical field of drug synthesis, and particularly relates to a preparation method of ceftezole acid.
Background
Ceftezole acid, chemically (6R) -8-oxo-7- [ (1H-1-tetrazolylacetyl) amino ] -3- [ [2- (1,3, 4-thiadiazolyl) thio ] methyl ] -5-thia-1-azabicyclo [4,2,0] oct-2-ene-2-carboxylic acid, is a semi-synthetic cephalosporin antibiotic synthesized and developed by japan tenuzolk drug company and marketed under the trade name of Ceolslin in 4 months of 1978. The medicine is applied later in China, the Hayao and Tianjin Xinfeng have raw material medicines and preparation production in 2002, and the annual growth rate of the use amount is 399% in recent years. The product is mainly used for treating infection caused by Staphylococcus aureus, Streptococcus pyogenes, pneumococcus, Escherichia coli, and pneumonia bacillus, such as septicemia, pneumonia, bronchitis, chronic respiratory system secondary infection caused by bronchiectasis infection, lung abscess, peritonitis, pyelonephritis, and cystitis.
At present, few reports on the synthesis process of ceftezole acid exist, and the existing process is as follows:
the first synthesis process comprises the following steps: taking tetrazole acetic acid as an initial raw material, preparing acyl chloride, preparing an intermediate 7-tetrazole acetamido cephalosporanic acid with 7-ACA, and synthesizing ceftezole acid with 2-mercapto-1, 3, 4-thiadiazole. The acyl chloride method causes environmental pollution, and has high cost and low yield. And the 7-bit acylation reaction is carried out, the reaction is carried out under the condition of low temperature, a large amount of nitrogen is used for cooling, the cost is increased, and the requirement on reaction equipment is high.
And a second synthesis process: the 7-ACA is used as an initial raw material and reacts with 1H-tetrahydrothiazole acetic acid under the catalysis of DCC to produce 7-tetrazole acetamido cephalosporanic acid, and then the 7-tetrazole acetamido cephalosporanic acid reacts with 2-mercapto-1, 3, 4-thiadiazole to produce ceftezole acid.
Disclosure of Invention
The invention aims to provide a novel preparation method of ceftezole acid aiming at the defects of the prior art, the preparation method shortens the reaction route, is simple to operate in the reaction process, has higher yield and purity, produces few by-products, has the advantage of environmental friendliness, and is suitable for industrial production.
A preparation method of ceftezole acid comprises the following steps:
(1) preparation of intermediate 1: firstly, 2-mercapto-1, 3, 4-thiadiazole, dimethyl carbonate and BF are mixed3Adding a dimethyl carbonate complex and a certain amount of acid into a reactor, stirring and dissolving, slowly dropwise adding 7-ACA, controlling the reaction at 0-10 ℃, stirring and reacting for 1h, introducing dry hydrogen chloride gas after the reaction is finished, cooling to-5-0 ℃ to precipitate crystals, centrifuging, and drying, wherein the purity of the product is over 99.3%;
(2) synthesis of ceftezole acid: adding tetrazoleacetic acid, a condensing agent, alkali, water and an organic solvent into a reaction bottle for dissolving, controlling the temperature to be 5-10 ℃, slowly adding the intermediate 1, stirring for reaction for 1.5h, controlling the residue of the intermediate 1 to be below 3%, adding water for hydrolysis at room temperature, adding dichloromethane for extraction and layering, adding activated carbon for decolorization, adding acetone for crystallization, centrifuging, and drying to obtain ceftezole acid;
the synthetic route is as follows:
Figure BDA0001873294200000021
preferably, the acid in the step (1) is acetic acid or carbonic acid, and the molar weight of the acid used is 0.5-1 times of that of the 2-mercapto-1, 3, 4-thiadiazole.
Preferably, the 2-mercapto-1, 3, 4-thiadiazole, 7-ACA, BF described in the step (1)3The molar ratio of dimethyl carbonate is 1:1: 2-3.
Preferably, the condensing agent in the step (2) is 2-methoxy-4, 6-dichloro-1, 3, 5-triazine or phenyl phosphorodiamidate, the molar amount of the condensing agent is 1-1.2 times of that of tetrazoleacetic acid, and the condensing agent is further preferably phenyl phosphorodiamidate.
Preferably, the base in step (2) is triethylamine, diethylamine, diisopropylethylamine or N-methylmorpholine, the molar amount of the base is 2 times that of the tetrazoleacetic acid, and more preferably, the base is diethylamine or diisopropylethylamine.
Preferably, the organic solvent in step (2) is dichloromethane, chloroform, tetrahydrofuran, dioxane, N-dimethylformamide or acetonitrile, and more preferably, the organic solvent is dichloromethane, chloroform or N, N-dimethylformamide.
Compared with the prior art, the invention has the beneficial effects that:
(1) the invention prepares ceftezole acid from the intermediate 1 and the tetrazoleacetic acid by a one-step method, shortens the reaction steps, has mild reaction conditions and simple and convenient operation, improves the total yield and purity of the product, and avoids the use of an acylation reagent which pollutes the environment.
(2) The method has the advantages of simple process, easy operation of reaction process, high product yield and purity, less by-products and suitability for industrial production.
Detailed Description
The present invention will be described in further detail with reference to specific examples, but the present invention is not limited thereto.
Example 1
Preparation of intermediate 1
Firstly, 11.82g (0.1mol) of 2-mercapto-1, 3, 4-thiadiazole, 120ml of dimethyl carbonate and BF are added3Dimethyl carbonate complex (0.2mol, as BF)3Calculated), 0.1mol of acetic acid is added into a reactor to be stirred and dissolved, then 7-ACA 27.23g (0.1mol) is slowly dripped, the reaction is controlled at 0-10 ℃, stirred and reacted for 1 hour, and then the reaction is carried outAnd after the reaction is finished, introducing dry hydrogen chloride gas, cooling to-5-0 ℃ to precipitate crystals, centrifuging, and drying to obtain 134.32 g of an intermediate, wherein the yield is 93%, and the purity is 99.4%.
Example 2
Preparation of intermediate 1
Firstly, 11.82g (0.1mol) of 2-mercapto-1, 3, 4-thiadiazole, 120ml of dimethyl carbonate and BF are added3Dimethyl carbonate complex (0.3mol, as BF)3Calculation) and 0.05mol of carbonic acid are added into a reactor to be stirred and dissolved, then 7-ACA35.39g (0.1mol) is slowly dripped, the reaction is controlled at 0-10 ℃, stirred and reacted for 1 hour, after the reaction is finished, dry hydrogen chloride gas is introduced, the temperature is reduced to-5-0 ℃, crystals are separated out, the centrifugation and the drying are carried out, 135.39 g of intermediate is obtained, the yield is 96%, and the purity is 99.5%.
Example 3
Preparation of intermediate 1
Firstly, 11.82g (0.1mol) of 2-mercapto-1, 3, 4-thiadiazole, 120ml of dimethyl carbonate and BF are added3Dimethyl carbonate complex (0.2mol, as BF)3Calculation) and 0.1mol of formic acid are added into a reactor and stirred for dissolution, then 7-ACA 27.23g (0.1mol) is slowly dripped, the reaction is controlled at 0-10 ℃, stirred for reaction for 1 hour, after the reaction is finished, dry hydrogen chloride gas is introduced, the temperature is reduced to-5-0 ℃, crystals are separated out, the centrifugation and the drying are carried out, 130.98 g of intermediate is obtained, the yield is 83 percent, and the purity is 98.3 percent.
Example 4
Preparation of ceftezole acid
Adding 11.91g (0.093mol) of tetrazoleacetic acid, 0.186mol of 2-methoxy-4, 6-dichloro-1, 3, 5-triazine, 0.093mol of triethylamine and 200ml of dichloromethane into a reaction bottle for dissolving, controlling the temperature to be 5-10 ℃, slowly adding 34.32g of the intermediate 1, stirring for reacting for 1.5h, controlling the residue of the intermediate 1 to be less than 3%, adding water for hydrolyzing at room temperature, adding dichloromethane for extraction and layering, adding activated carbon for decoloring, adding acetone for crystallizing, centrifuging and drying to obtain 38.78g of ceftezole acid, wherein the yield is 94%, the purity is 99.3% and the maximum single impurity is 0.06%.
Example 5
Preparation of ceftezole acid
Adding 12.29g (0.096mol) of tetrazoleacetic acid, 0.115mol of phenyl dichlorophosphate, 0.192mol of diethylamine and 200ml of chloroform into a reaction bottle for dissolving, controlling the temperature to be 5-10 ℃, slowly adding 35.39g of the intermediate 1, stirring for reacting for 1.5h, controlling the residue of the intermediate 1 to be less than 3%, adding water for hydrolyzing at room temperature, adding dichloromethane for extraction and layering, adding activated carbon for decoloring, adding acetone for crystallizing, centrifuging, and drying to obtain 40.84g of ceftezole acid, wherein the yield is 96%, the purity is 99.4%, and the maximum single impurity content is 0.04%.
Example 6
Preparation of ceftezole acid
Adding 10.63g (0.083mol) of tetrazoleacetic acid, 0.083mol) of 4, 6-dimethoxy-2-chloro-1, 3, 5-triazine, 0.166mol of diethylamine and 200ml of DMF into a reaction bottle for dissolving, controlling the temperature to be 5-10 ℃, slowly adding 30.98g of the intermediate 1, stirring for reaction for 1.5h, controlling the residue of the intermediate 1 to be below 3%, adding water for hydrolysis at room temperature, adding dichloromethane for extraction and separation, adding activated carbon for decolorization, adding acetone for crystallization, centrifuging and drying to obtain 31.45g of ceftezole acid, wherein the yield is 85%, the purity is 98.8% and the maximum single impurity is 0.15%.

Claims (5)

1. The preparation method of ceftezole acid is characterized by comprising the following steps:
(1) preparation of intermediate 1: firstly, 2-mercapto-1, 3, 4-thiadiazole, dimethyl carbonate and BF are mixed3Adding a dimethyl carbonate complex and a certain amount of acid into a reactor, stirring and dissolving, slowly dropwise adding 7-ACA, controlling the reaction at 0-10 ℃, stirring and reacting for 1h, introducing dry hydrogen chloride gas after the reaction is finished, cooling to-5-0 ℃ to precipitate crystals, centrifuging, and drying, wherein the purity of the product is over 99.3%; the acid is acetic acid or carbonic acid, and the molar weight of the acid is 0.5 to 1 time of that of the 2-mercapto-1, 3, 4-thiadiazole;
(2) synthesis of ceftezole acid: adding tetrazoleacetic acid, a condensing agent, alkali, water and an organic solvent into a reaction bottle for dissolving, controlling the temperature to be 5-10 ℃, slowly adding the intermediate 1, stirring for reaction for 1.5h, controlling the residue of the intermediate 1 to be below 3%, adding water for hydrolysis at room temperature, adding dichloromethane for extraction and layering, adding activated carbon for decolorization, adding acetone for crystallization, centrifuging, and drying to obtain ceftezole acid; the condensing agent is 2-methoxy-4, 6-dichloro-1, 3, 5-triazine or phenyl dichlorophosphate, and the molar amount of the condensing agent is 1-1.2 times that of the tetrazoleacetic acid; the alkali is triethylamine, diethylamine, diisopropylethylamine or N-methylmorpholine, and the molar amount of the alkali is 2 times of that of the tetrazoleacetic acid; the organic solvent is dichloromethane, chloroform, tetrahydrofuran, dioxane, N-dimethylformamide or acetonitrile; the molar ratio of the intermediate 1 to the tetrazoleacetic acid is 1: 1-1.2;
the synthetic route is as follows:
Figure FDA0002421511850000011
2. the method according to claim 1, wherein the 2-mercapto-1, 3, 4-thiadiazole, 7-ACA, BF prepared in the step (1)3The molar ratio of dimethyl carbonate is 1:1: 2-3.
3. The method of claim 1, wherein the condensing agent is phenyl dichlorophosphate.
4. The method of claim 1, wherein the base is diethylamine or diisopropylethylamine.
5. The method according to claim 1, wherein the organic solvent is dichloromethane, chloroform or N, N-dimethylformamide.
CN201811387629.0A 2018-11-21 2018-11-21 Preparation method of ceftezole acid Active CN109485658B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811387629.0A CN109485658B (en) 2018-11-21 2018-11-21 Preparation method of ceftezole acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811387629.0A CN109485658B (en) 2018-11-21 2018-11-21 Preparation method of ceftezole acid

Publications (2)

Publication Number Publication Date
CN109485658A CN109485658A (en) 2019-03-19
CN109485658B true CN109485658B (en) 2020-06-09

Family

ID=65696398

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811387629.0A Active CN109485658B (en) 2018-11-21 2018-11-21 Preparation method of ceftezole acid

Country Status (1)

Country Link
CN (1) CN109485658B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110563749A (en) * 2019-09-11 2019-12-13 山东罗欣药业集团恒欣药业有限公司 Preparation method of cefotiam hydrochloride compound
CN110437256A (en) * 2019-09-20 2019-11-12 山东罗欣药业集团恒欣药业有限公司 A kind of synthesis technology of Cefazedone
CN110563750B (en) * 2019-09-20 2022-08-23 山东罗欣药业集团恒欣药业有限公司 Synthesis method of cefazedone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100506210C (en) * 2008-01-18 2009-07-01 山东罗欣药业股份有限公司 Ceftezole sodium powder injection and synthesizing method thereof
CN102617606B (en) * 2012-03-31 2014-04-16 哈药集团制药总厂 Method for preparing ceftezole sodium compound
CN102977122A (en) * 2012-10-08 2013-03-20 江苏德峰药业有限公司 Ceftezole acid preparation method
CN105131018B (en) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 A kind of preparation method of ceftezole acid
CN106967092B (en) * 2017-04-12 2019-05-03 山东裕欣药业有限公司 A kind of preparation method of Cefazedone

Also Published As

Publication number Publication date
CN109485658A (en) 2019-03-19

Similar Documents

Publication Publication Date Title
CN101613359B (en) Method for synthesizing cefuroxime sodium
CN109485658B (en) Preparation method of ceftezole acid
CN102030762B (en) Preparation method of cefprozil
CN116535421A (en) Synthesis method of ceftiofur sodium
CN109336907B (en) Preparation method of ceftezole sodium
CN101735250A (en) Ceftezole sodium compound with novel route
CN112321605B (en) Preparation method of piperacillin
CN101941982B (en) Novel preparation method of pharmaceutical ceforanide
CN109517001B (en) Preparation method of cefotiam hydrochloride
CN110003238A (en) A kind of preparation method of cefotiam
CN109553626B (en) Refining method of ceftizoxime sodium
CN111440197A (en) Preparation method of ceftriaxone sodium
CN110128449A (en) 7- phenylacetyl amido -3- desacetoxycephalosporanic acid salt and its preparation method and application
CN108299469B (en) Preparation method of cefotiam hydrochloride
CN109503629B (en) Synthesis method of ceftizoxime acid
CN108033972B (en) Synthesis method of cefprozil
CN109912625B (en) Process method for reducing ceftazidime impurity H
CN108299470B (en) Preparation method of cefteram pivoxil
CN112694488B (en) Synthesis method of L-type cefamandole nafate
CN111233894B (en) Cefditoren pivoxil delta3Process for the preparation of isomers
CN110563749A (en) Preparation method of cefotiam hydrochloride compound
CN113185538B (en) Preparation method of cefpodoxime acid
CN112321607B (en) Method for synthesizing ceftizoxime acid by one-pot method
CN118754896B (en) Ceftulon Process for the preparation of picoesters
CN109535181B (en) Acylation reaction process of ceftezole acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant